SV

Street Verdict

Analyst Scorecard

A record of what Sumeet Bagadia said publicly, with the source. Not advice.

“Bullish on Gland Pharma for intraday trading, recommending a buy at ₹1597.90 with a target of ₹1710 and a stop loss at ₹1542.”

Sumeet Bagadia’s track record (trackable calls only): 1528 graded calls · 95% CI 32–37%

Gland Pharma LtdBullishCalled 27 Feb 2025Graded 03 Mar 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

Entry: ₹1,597.9, as stated.

Target ₹1,710, stop ₹1,542, as stated.

Window: 30 days, the time frame the call states ("intraday").

The stop ₹1,542 was reached on a close before the target ₹1,710. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹1597.9 on 2025-02-28 (stated entry ₹1597.9, LEVEL_CMP entry, filled); stop ₹1542 breached at close ₹1538.8 on 2025-03-03. Window 30 days — rule H1: the quote says "intraday" (a one-day claim, judged over 30 days; MISS if neither level is reached).

Tracking Gland Pharma Ltd since this call

1-year tracking window
Read the original articleSee Sumeet Bagadia’s full track record